SCHEMBL1102944

SCHEMBL1102944

c1ccc(-c2cc(-c3ccccc3)cc(-c3c4ccccc4c(-c4ccccc4)c4ncccc34)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 2/20 0.39
MAOB P27338 1/20 0.38
ESR1 P03372 5/20 0.38
ESR2 Q92731 4/20 0.38
ALDH1A1 P00352 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.37
NPC1 O15118 2/20 0.37
HSP90AA1 P07900 1/20 0.37
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
CKS1B P61024 1/20 0.35
GLO1 Q04760 1/20 0.35
SKP2 Q13309 1/20 0.35
MMP2 P08253 1/20 0.35
CCR1 P32246 2/20 0.35
CCR8 P51685 2/20 0.35
CYP19A1 P11511 1/20 0.35
KDM4E B2RXH2 1/20 0.35
RAB9A P51151 1/20 0.35
PIK3CD O00329 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1102864 0.98 TOP1 (0.40) TOP1MAOBESR1ESR2ALDH1A1
SCHEMBL1102978 0.92 ESR1 (0.39) TOP1MAOBESR1ESR2ALDH1A1
SCHEMBL1103108 0.91 ESR1 (0.41) TOP1MAOBESR1ESR2ALDH1A1
SCHEMBL1103113 0.91 ESR1 (0.41) TOP1MAOBESR1ESR2ALDH1A1
SCHEMBL1102990 0.91 L3MBTL1 (0.41) TOP1MAOBESR1ESR2ALDH1A1
SCHEMBL1102789 0.91 L3MBTL1 (0.41) TOP1MAOBESR1ESR2ALDH1A1
SCHEMBL1102949 0.91 L3MBTL1 (0.41) TOP1MAOBESR1ESR2ALDH1A1
SCHEMBL1103097 0.91 L3MBTL1 (0.41) TOP1MAOBESR1ESR2ALDH1A1
SCHEMBL1102824 0.91 L3MBTL1 (0.43) TOP1MAOBESR1ESR2ALDH1A1
SCHEMBL1103005 0.90 ESR1 (0.38) TOP1MAOBESR1ESR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-8153279-B2 Organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2012-04-10 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100033083-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same ORMDL3, OCIAD2, OCIAD1 TOP1 4307/4885MAOB 1209/4885ESR1 1038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.